A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Folates for reduction of risk of neural tube defects: using oral contraceptives as a source of folate
Open Access Journal of Contraception
The evidence that folates reduce the risk of neural tube defects (NTDs) is so compelling that supplementation has been recommended by every relevant authority. The Cochrane Database of Systematic Reviews has determined that folate supplementation should be rated as a Grade 1 recommendation. United States Preventive Health Services Task Force, the US Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC) have all produced clear guidelines for suchdoi:10.2147/oajc.s17425 fatcat:cn3qrzghvze3tnmwi5g66ydksq